Latest news - Johnson & Johnson
Oct 10, 2024 · A collection of stories that highlight the way Johnson & Johnson is making an impact in the lives of its consumers, and the latest press releases from the company.
Press Releases - Johnson & Johnson
Explore all Johnson & Johnson published press releases by date and/or topic of news.
Johnson & Johnson Announces Plans to Accelerate Innovation, …
Nov 12, 2021 · The new Johnson & Johnson would continue to play a leading role in advancing the industry forward by creating novel solutions, bringing together treatments spanning therapeutics, robotics, artificial intelligence and more, to change the way diseases are prevented, intercepted and eventually cured.
Johnson & Johnson: Changing health for humanity
What you need to know about Johnson & Johnson ’s 2023 transparency report. The annual report has just been released—here are key takeaways that showcase the company’s commitment to creating a more sustainable, equitable and innovative healthcare system. Read more.
Johnson & Johnson Announces Real-World Evidence and Phase 3 …
Sep 21, 2021 · Johnson & Johnson single-shot vaccine showed strong and long-lasting protection in the real world The largest real-world evidence study for a COVID-19 vaccine reported to date in the U.S. demonstrated stable vaccine effectiveness of 79 percent (CI, 77%-80%) for COVID-19-related infections and 81 percent (CI, 79%-84%) for COVID-19-related ...
News | Johnson & Johnson - Investors
Nov 7, 2024 · Johnson & Johnson highlights innovative neuropsychiatry portfolio and pipeline at Psych Congress. Download. Oct 23, 2024. DARZALEX® (daratumumab)-SC based quadruplet regimen approved by the European Commission for patients with newly diagnosed multiple myeloma who are transplant-eligible. Download.
Investor Relations | Johnson & Johnson
Oct 15, 2024 · You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact us with any questions or search this site for more information.
Johnson & Johnson reports Q3 2024 results
Oct 15, 2024 · Johnson & Johnson is updating its 2024 guidance, including adjusted operational EPS guidance, to reflect improved performance and the impact from the recent acquisition of V-Wave.
Real World Evidence Shows Johnson & Johnson COVID-19 Vaccine ...
NEW BRUNSWICK, N.J., January 6, 2022 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced new results from the largest study to date on the durability of COVID-19 vaccines in the United States (U.S.), showing that a single shot of the Johnson & Johnson COVID-19 vaccine resulted in long-lasting protection for up to six months against ...
Oncology latest news - Johnson & Johnson
Johnson & Johnson is restoring the true meaning of healthcare by developing advanced treatments and smarter and less invasive solutions for today’s most complex diseases.